AGIOS PHARMACEUTICAL (AGIO) insider trading activity (SEC Form 4). Over the trailing 90 days, AGIO insiders filed 0 purchases totalling $0 and 2 sales totalling $371K — net SELLING of $371K. Most recent filing: Oct 28, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Gheuens Sarah | Chief Medical Officer | S SaleOE | — | $37.69 | $296K | filing |
| Oct 23, 2026 | Gheuens Sarah | Chief Medical Officer | S SaleOE | — | $37.53 | $75K | filing |
| Aug 6, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | — | $30.48 | $914K | filing |
| Jul 2, 2026 | Gheuens Sarah | Chief Medical Officer | S SaleOE | — | $37.56 | $151K | filing |